Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of SSRI Response in OCD
NCT02431845Recruiting
- Sponsor
- Severance Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
Open-label, single-arm trial in obsessive compulsive disorder (OCD), sponsored by Severance Hospital. Primary endpoint: Yale-Brown Obsessive-Compulsive Scale at 1 year. Started Jan 2013; status: recruiting.
02
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02431845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431845.